about
Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome AtlasmiR-100 induces epithelial-mesenchymal transition but suppresses tumorigenesis, migration and invasionAssessing the clinical utility of cancer genomic and proteomic data across tumor types.BM-Map: an efficient software package for accurately allocating multireads of RNA-sequencing data.A Bayesian Graphical Model for Integrative Analysis of TCGA Data.BM-SNP: A Bayesian Model for SNP Calling Using High Throughput Sequencing Data.A Bayesian Model for SNP Discovery Based on Next-Generation Sequencing Data.BM-map: Bayesian mapping of multireads for next-generation sequencing data.ATM-mediated stabilization of ZEB1 promotes DNA damage response and radioresistance through CHK1.Predicting the lethal phenotype of the knockout mouse by integrating comprehensive genomic dataThe Pan-Cancer analysis of pseudogene expression reveals biologically and clinically relevant tumour subtypes.miR-205 acts as a tumour radiosensitizer by targeting ZEB1 and Ubc13.Nonparametric Bayesian Bi-Clustering for Next Generation Sequencing Count Data.α-catenin acts as a tumour suppressor in E-cadherin-negative basal-like breast cancer by inhibiting NF-κB signalling.Gene co-expression network analysis reveals common system-level properties of prognostic genes across cancer types.Comprehensive molecular characterization of mitochondrial genomes in human cancersPublisher Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancersA study to evaluate the immunogenicity and shedding of live attenuated influenza vaccine strains in children 24-<48 months of ageAuthor Correction: Comprehensive molecular characterization of mitochondrial genomes in human cancers
P50
Q24595911-D217D7B5-D3DD-4F29-AAB3-4244130F467AQ27316744-EAE68DD7-30F8-4EA0-9EBC-D2E3168CC411Q30487077-38FF5E13-212E-4649-8CA7-C8597EBB0C67Q30584014-2465CB55-46BE-4001-9ED8-C29E38C8F5E2Q30928917-CDBF22EB-EE21-4A1E-8382-F5ACACF54C7AQ30992729-4CC8FEE9-0176-4F00-B44E-4BAA8A52BA24Q31034868-2E759844-5D78-4D68-A53D-947BCF97DC2CQ33881427-2D20D803-C767-4E8B-9536-0949362B6312Q34115685-024D0F0F-C4DA-445A-9936-BEC12799CDA1Q34196685-01961119-F0C9-411D-BFEE-D35EB0481E93Q35117286-9C4EC283-EF4A-45D6-8015-A1E6C2E6BE82Q35225778-18681EAC-8867-49C3-8485-4B38C2530BA8Q35738492-05A9C847-130E-490C-ADEB-330993F31C83Q37619596-D2F5845D-7502-4DBB-BAB2-F3A4DCA6A2C7Q37632815-EC9BDE0D-481F-493C-BE35-96043180A48EQ89556802-7DD0FE31-255E-417B-9C62-1205339F3353Q89665351-8128AD91-2E56-4541-97B7-EC9B70FC3DE5Q91652613-DC3575F5-E88B-4BB4-B39E-A452F385C52FQ93270788-11A85E73-455C-4CA7-B24E-B21D2B45A9A5
P50
description
onderzoeker
@nl
researcher ORCID: 0000-0003-4706-7897
@en
name
Yuan Yuan
@ast
Yuan Yuan
@en
Yuan Yuan
@es
Yuan Yuan
@nl
Yuan Yuan
@sl
type
label
Yuan Yuan
@ast
Yuan Yuan
@en
Yuan Yuan
@es
Yuan Yuan
@nl
Yuan Yuan
@sl
prefLabel
Yuan Yuan
@ast
Yuan Yuan
@en
Yuan Yuan
@es
Yuan Yuan
@nl
Yuan Yuan
@sl
P106
P2456
P31
P496
0000-0003-4706-7897